Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199218-10-2014
18-10-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Natco Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199213-10-2014
Revised report under clause 35A
Natco Pharma Ltd has submitted to BSE a copy of the revised report under clause 35A.10-10-2014
Shareholding Pattern For September 30, 2014
Natco Pharma Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014.08-10-2014
Disclosure of Voting results of AGM (Clause 35A)
Natco Pharma Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting (AGM) of the Company held on September 27, 2014, under Clause 35A.29-09-2014
Outcome of AGM
Natco Pharma Ltd has informed BSE that the 31st Annual General Meeting (AGM) of the Company was held on September 27, 2014.29-09-2014
Natco's Kothur Formulation Facility found acceptable by USFDA
Natco Pharma Ltd has informed BSE regarding a Press Release dated September 18, 2014, titled "Natco's Kothur Formulation Facility found acceptable by USFDA".18-09-2014
Breckenridge/NATCO files ANDA for Everolimus, 0.25mg, 0.5mg, and 0.75mg Tablets
Natco Pharma Ltd has informed BSE regarding a Press Release dated September 05, 2014, titled "Breckenridge/NATCO files ANDA for Everolimus, 0.25mg, 0.5mg, and 0.75mg Tablets"05-09-2014
NATCOs marketing partner, Mylan Inc., files ANDA for Three Times Per Week Generic Copaxone 40 mg/mL
Natco Pharma Ltd has informed BSE regarding a Press Release dated August 30, 2014, titled "NATCOs marketing partner, Mylan Inc., files ANDA for Three Times Per Week Generic Copaxone 40 mg/mL".30-08-2014
Appointment of Additional Directors
Natco Pharma Ltd has informed BSE that the following:1. Exim Bank with drawn their Nominee Director from the Board of Directors and the Board of Directors by way Resolution by circulation appointed Mr. T V Rao as Additional Directors of the Company.2. Dr. Mrs. Leela Digumarti, appointed by the Board of Directors as Additional Director by way of Resolution by Circulation.26-08-2014